Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CTMX
#2162
CytomX Therapeutics, Inc.
5.3
7
-0.37%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.37%
Monthly Change
-9.60%
6 month change
+156.94%
Cambio anual
+701.49%
Cierres anteriores
5.3
9
Open
5.3
7
Bid
Ask
Low
5.3
7
High
5.3
7
Volumen
86
Markets
Acciones
Atención Sanitaria
CTMX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates
CytomX en Cumbre Guggenheim: Prometedor tratamiento para cáncer colorrectal
CytomX en la Cumbre de Guggenheim: Prometedor camino para tratamiento de CRC
CytomX at Guggenheim Summit: Promising CRC Treatment Path
Qiagen (QGEN) Meets Q4 Earnings Estimates
Las acciones de CytomX Therapeutics alcanzan un máximo de 52 semanas a 6,16 dólares
CytomX Therapeutics stock hits 52-week high at 6.16 USD
Regenxbio (RGNX) Soars 5.4%: Is Further Upside Left in the Stock?
Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock?
Piper Sandler raises CytomX Therapeutics stock price target to $10 on cancer drug data
CytomX Stock Rises 31% in a Month: Here's What You Should Know